Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells As a Safe and Accessible Source of Endothelial Cells

Overview

Journal Stem Cells Dev

Date 2017 Nov 10

PMID 29117787

Citations 6

Authors

Pavel Simara

Lenka Tesarova

Daniela rehakova

Simon Farkas

Barbara Salingova

Katerina Kutalkova

Eva Vavreckova

Pavel Matula

Petr Matula

Lenka Veverkova

Irena Koutna

Affiliations

Soon will be listed here.

Abstract

New approaches in regenerative medicine and vasculogenesis have generated a demand for sufficient numbers of human endothelial cells (ECs). ECs and their progenitors reside on the interior surface of blood and lymphatic vessels or circulate in peripheral blood; however, their numbers are limited, and they are difficult to expand after isolation. Recent advances in human induced pluripotent stem cell (hiPSC) research have opened possible avenues to generate unlimited numbers of ECs from easily accessible cell sources, such as the peripheral blood. In this study, we reprogrammed peripheral blood mononuclear cells, human umbilical vein endothelial cells (HUVECs), and human saphenous vein endothelial cells (HSVECs) into hiPSCs and differentiated them into ECs. The phenotype profiles, functionality, and genome stability of all hiPSC-derived ECs were assessed and compared with HUVECs and HSVECs. hiPSC-derived ECs resembled their natural EC counterparts, as shown by the expression of the endothelial surface markers CD31 and CD144 and the results of the functional analysis. Higher expression of endothelial progenitor markers CD34 and kinase insert domain receptor (KDR) was measured in hiPSC-derived ECs. An analysis of phosphorylated histone H2AX (γH2AX) foci revealed that an increased number of DNA double-strand breaks upon reprogramming into pluripotent cells. However, differentiation into ECs restored a normal number of γH2AX foci. Our hiPSCs retained a normal karyotype, with the exception of the HSVEC-derived hiPSC line, which displayed mosaicism due to a gain of chromosome 1. Peripheral blood from adult donors is a suitable source for the unlimited production of patient-specific ECs through the hiPSC interstage. hiPSC-derived ECs are fully functional and comparable to natural ECs. The protocol is eligible for clinical applications in regenerative medicine, if the genomic stability of the pluripotent cell stage is closely monitored.

Citing Articles

In vitro human cell culture models in a bench-to-bedside approach to epilepsy.

Danacikova S, Straka B, Danek J, Korinek V, Otahal J Epilepsia Open. 2024; 9(3):865-890.

PMID: 38637998 PMC: 11145627. DOI: 10.1002/epi4.12941.

Generation of Urothelial Cells from Mouse-Induced Pluripotent Stem Cells.

Zhang D, Sun F, Yao H, Wang D, Bao X, Wang J Int J Stem Cells. 2022; 15(4):347-358.

PMID: 35769056 PMC: 9705153. DOI: 10.15283/ijsc21250.

Histone Variant macroH2A1.1 Enhances Nonhomologous End Joining-dependent DNA Double-strand-break Repair and Reprogramming Efficiency of Human iPSCs.

Giallongo S, rehakova D, Biagini T, Lo Re O, Raina P, Lochmanova G Stem Cells. 2022; 40(1):35-48.

PMID: 35511867 PMC: 9199840. DOI: 10.1093/stmcls/sxab004.

A novel method to improve the osteogenesis capacity of hUCMSCs with dual-directional pre-induction under screened co-culture conditions.

Rong Q, Li S, Zhou Y, Geng Y, Liu S, Wu W Cell Prolif. 2019; 53(2):e12740.

PMID: 31820506 PMC: 7078770. DOI: 10.1111/cpr.12740.

The Effect of Uncoated SPIONs on hiPSC-Differentiated Endothelial Cells.

Salingova B, Simara P, Matula P, Zajickova L, Synek P, Jasek O Int J Mol Sci. 2019; 20(14).

PMID: 31331030 PMC: 6678752. DOI: 10.3390/ijms20143536.

References

Orlova V, van den Hil F, Petrus-Reurer S, Drabsch Y, Ten Dijke P, Mummery C . Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells. Nat Protoc. 2014; 9(6):1514-31. DOI: 10.1038/nprot.2014.102. View

Peichev M, Naiyer A, Pereira D, Zhu Z, Lane W, Williams M . Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000; 95(3):952-8. View

Cooke J . Flow, NO, and atherogenesis. Proc Natl Acad Sci U S A. 2003; 100(3):768-70. PMC: 298674. DOI: 10.1073/pnas.0430082100. View

Chou B, Mali P, Huang X, Ye Z, Dowey S, Resar L . Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 2011; 21(3):518-29. PMC: 3193421. DOI: 10.1038/cr.2011.12. View

White M, Rufaihah A, Liu L, Ghebremariam Y, Ivey K, Cooke J . Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells. Stem Cells. 2012; 31(1):92-103. PMC: 3528812. DOI: 10.1002/stem.1267. View

Ben-David U, Mayshar Y, Benvenisty N . Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell. 2011; 9(2):97-102. DOI: 10.1016/j.stem.2011.06.013. View

Huang L, Perrault C, Coelho-Martins J, Hu C, Dulong C, Varna M . Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy. J Hematol Oncol. 2013; 6:49. PMC: 3717049. DOI: 10.1186/1756-8722-6-49. View

Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T . Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med. 2017; 376(11):1038-1046. DOI: 10.1056/NEJMoa1608368. View

Herring M, Gardner A, Glover J . A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery. 1978; 84(4):498-504. View

10.

Ng E, Davis R, Stanley E, Elefanty A . A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat Protoc. 2008; 3(5):768-76. DOI: 10.1038/nprot.2008.42. View

11.

Nourse M, Halpin D, Scatena M, Mortisen D, Tulloch N, Hauch K . VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol. 2009; 30(1):80-9. PMC: 2814336. DOI: 10.1161/ATVBAHA.109.194233. View

12.

Medina R, Barber C, Sabatier F, Dignat-George F, Melero-Martin J, Khosrotehrani K . Endothelial Progenitors: A Consensus Statement on Nomenclature. Stem Cells Transl Med. 2017; 6(5):1316-1320. PMC: 5442722. DOI: 10.1002/sctm.16-0360. View

13.

Li Y, Liu T, Van Halm-Lutterodt N, Chen J, Su Q, Hai Y . Reprogramming of blood cells into induced pluripotent stem cells as a new cell source for cartilage repair. Stem Cell Res Ther. 2016; 7:31. PMC: 4756426. DOI: 10.1186/s13287-016-0290-7. View

14.

Stead E, White J, Faast R, Conn S, Goldstone S, Rathjen J . Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene. 2002; 21(54):8320-33. DOI: 10.1038/sj.onc.1206015. View

15.

de la Puente P, Muz B, Azab F, Azab A . Cell trafficking of endothelial progenitor cells in tumor progression. Clin Cancer Res. 2013; 19(13):3360-8. DOI: 10.1158/1078-0432.CCR-13-0462. View

16.

Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1(1):27-31. DOI: 10.1038/nm0195-27. View

17.

Shah A, Smogorzewska E, Hannum C, Crooks G . Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro. Blood. 1996; 87(9):3563-70. View

18.

Mukai N, Akahori T, Komaki M, Li Q, Kanayasu-Toyoda T, Ishii-Watabe A . A comparison of the tube forming potentials of early and late endothelial progenitor cells. Exp Cell Res. 2007; 314(3):430-40. DOI: 10.1016/j.yexcr.2007.11.016. View

19.

Laurent L, Ulitsky I, Slavin I, Tran H, Schork A, Morey R . Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell. 2011; 8(1):106-18. PMC: 3043464. DOI: 10.1016/j.stem.2010.12.003. View

20.

Folkman J . Angiogenesis: an organizing principle for drug discovery?. Nat Rev Drug Discov. 2007; 6(4):273-86. DOI: 10.1038/nrd2115. View